Latest news from Iconovo

Iconovo to present at Redeye Life Science Day November 23
Johan Wäborg, CEO, will present Iconovo at Redeye Life Science Day. Learn more about why you should invest in Iconovo and get excited by our vision to…

Busy days for Iconovo at BIO-Europe
Iconovo had three hectic days at BIO-Europe, with a large number of meetings with potential partners. The company especially highlighted their latest innovation,…

Iconovo and Arcede Pharma take the next step in the development of a new treatment for COPD
Iconovo AB (publ), which develops complete inhalation products for a global market, and Arcede Pharma, which develops inhalation treatments for COPD and…